Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer

FHS
July 24, 2024
10:31 am

Metrion Biosciences Ltd (“Metrion”), the specialist preclinical contract research organization (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as Chief Commercial Officer (CCO). Chris will work alongside the Company’s expert leadership team to drive commercial strategy and lead global business development and marketing activities.

Louisiana Limits Scope of Noncompetes for Physicians

A Louisiana law passed unanimously by the state’s legislature and signed by Gov. Jeff Landry (R) in May could dramatically change noncompete contracts between physicians

July 2, 2024

Walgreens reports a $5.8 billion charge due to clinic operator VillageMD

Walgreens is cutting down on a part of its business it once saw as a key part of its future. The health giant reported a

March 29, 2024

Study highlights exercise as a powerful tool to fight depression

Exercise can be a powerful tool to fight depression and should be routinely prescribed as part of treatment plans, according to University of Queensland research.

February 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.